Literature DB >> 35727428

MRI biomarker of muscle composition is associated with severity of pelvic organ prolapse.

L Neshatian1, J P Lam2, B H Gurland3, T Liang4, L Becker5, V R Sheth4.   

Abstract

BACKGROUND: The pathophysiology of pelvic organ prolapse is largely unknown. We hypothesized that reduced muscle mass on magnetic resonance defecography (MRD) is associated with increased pelvic floor laxity. The aim of this study was to compare the psoas and puborectalis muscle mass composition and cross-sectional area among patients with or without pelvic laxity.
METHODS: An observational retrospective study was conducted on women > age 18 years old who had undergone MRD for pelvic floor complaints from January 2020 to December 2020 at Stanford Pelvic Health Center. Pelvic floor laxity, pelvic organ descent, and rectal prolapse were characterized by standard measurements on MRD and compared to the psoas (L4 level) and puborectalis muscle index (cross-sectional area adjusted by height) and relative fat fraction, quantified by utilizing a 2-point Dixon technique. Regression analysis was used to quantify the association between muscle characteristics and pelvic organ measurements.
RESULTS: The psoas fat fraction was significantly elevated in patients with abnormally increased resting and strain H and M lines (p < 0.05) and increased with rising grades of Oxford rectal prolapse (p = 0.0001), uterovaginal descent (p = 0.001) and bladder descent (p = 0.0005). In multivariate regression analysis, adjusted for age and body mass index, the psoas fat fraction (not muscle index) was an independent risk factor for abnormal strain H and M line; odds ratio (95% confidence interval) of 17.8 (2-155.4) and 18.5 (1.3-258.3) respectively, and rising Oxford grade of rectal prolapse 153.9 (4.4-5383) and bladder descent 12.4 (1.5-106). Puborectalis fat fraction was increased by rising grades of Oxford rectal prolapse (p = 0.0002).
CONCLUSIONS: Severity of pelvic organ prolapse appears to be associated with increasing psoas muscle fat fraction, a biomarker for reduced skeletal muscle mass. Future prospective research is needed to determine if sarcopenia may predict postsurgical outcomes after pelvic organ prolapse repair.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Pelvic organ prolapse; Psoas cross- sectional area; Psoas muscle index; Rectal prolapse; Sarcopenia

Mesh:

Substances:

Year:  2022        PMID: 35727428     DOI: 10.1007/s10151-022-02651-8

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.699


  21 in total

1.  Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery.

Authors:  Marie Hanaoka; Masamichi Yasuno; Megumi Ishiguro; Shinichi Yamauchi; Akifumi Kikuchi; Michiyo Tokura; Toshiaki Ishikawa; Eiji Nakatani; Hiroyuki Uetake
Journal:  Int J Colorectal Dis       Date:  2017-02-11       Impact factor: 2.571

2.  Psoas cross-sectional area as a predictor of mortality and a diagnostic tool for sarcopenia in hip fracture patients.

Authors:  Seong-Eun Byun; Sujin Kim; Kyu-Hwang Kim; Yong-Chan Ha
Journal:  J Bone Miner Metab       Date:  2019-01-08       Impact factor: 2.626

3.  Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection?

Authors:  Aaron L Womer; Justin T Brady; Kevin Kalisz; Nilam D Patel; Raj M Paspulati; Harry L Reynolds; Timothy M Pawlik; Scott R Steele
Journal:  Am J Surg       Date:  2017-11-21       Impact factor: 2.565

Review 4.  Sarcopenia - Molecular mechanisms and open questions.

Authors:  Petra Wiedmer; Tobias Jung; José Pedro Castro; Laura C D Pomatto; Patrick Y Sun; Kelvin J A Davies; Tilman Grune
Journal:  Ageing Res Rev       Date:  2020-10-29       Impact factor: 10.895

5.  MRI-Derived Biomarkers Related to Sarcopenia: A Systematic Review.

Authors:  Marina Codari; Moreno Zanardo; Maria Eugenia di Sabato; Elisabetta Nocerino; Carmelo Messina; Luca Maria Sconfienza; Francesco Sardanelli
Journal:  J Magn Reson Imaging       Date:  2019-09-13       Impact factor: 4.813

6.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

7.  Prevalence of symptomatic pelvic floor disorders in US women.

Authors:  Ingrid Nygaard; Matthew D Barber; Kathryn L Burgio; Kimberly Kenton; Susan Meikle; Joseph Schaffer; Cathie Spino; William E Whitehead; Jennifer Wu; Debra J Brody
Journal:  JAMA       Date:  2008-09-17       Impact factor: 56.272

Review 8.  Epidemiological trends and future care needs for pelvic floor disorders.

Authors:  Alexis A Dieter; Maggie F Wilkins; Jennifer M Wu
Journal:  Curr Opin Obstet Gynecol       Date:  2015-10       Impact factor: 1.927

Review 9.  Physical activity and the pelvic floor.

Authors:  Ingrid E Nygaard; Janet M Shaw
Journal:  Am J Obstet Gynecol       Date:  2015-09-06       Impact factor: 8.661

10.  Prevalence of sarcopenia in older women with pelvic floor dysfunction.

Authors:  Rávida R L Silva; Janaína F V Coutinho; Camila T M Vasconcelos; José Ananias Vasconcelos Neto; Rachel Gabriel B Barbosa; Marília B Marques; Dayana M Saboia; Juliana C Maia
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2021-06-25       Impact factor: 2.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.